Tower Research Capital (TRC)’s Aravive, Inc. Common Stock ARAV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25,744
| Closed | -$3.19K | – | 6327 |
|
|
2023
Q4 | $3.19K | Sell |
25,744
-348
| -1% | -$48 | ﹤0.01% | 5115 |
|
|
2023
Q3 | $3.44K | Buy |
26,092
+15,177
| +139% | +$9.54K | ﹤0.01% | 5002 |
|
|
2023
Q2 | $13.8K | Buy |
10,915
+8,500
| +352% | +$13.8K | ﹤0.01% | 3745 |
|
|
2023
Q1 | $5K | Sell |
2,415
-18,509
| -88% | -$34.8K | ﹤0.01% | 5024 |
|
|
2022
Q4 | $27K | Buy |
20,924
+6,339
| +43% | +$8.09K | ﹤0.01% | 2860 |
|
|
2022
Q3 | $12K | Buy |
14,585
+2,657
| +22% | +$2.29K | ﹤0.01% | 4400 |
|
|
2022
Q2 | $12K | Buy |
11,928
+10,662
| +842% | +$14.1K | ﹤0.01% | 4331 |
|
|
2022
Q1 | $2K | Sell |
1,266
-3,642
| -74% | -$7.84K | ﹤0.01% | 5650 |
|
|
2021
Q4 | $11K | Buy |
4,908
+4,079
| +492% | +$13.6K | ﹤0.01% | 4490 |
|
|
2021
Q3 | $3K | Buy |
829
+114
| +16% | +$487 | ﹤0.01% | 5167 |
|
|
2021
Q2 | $4K | Sell |
715
-12,755
| -95% | -$67.5K | ﹤0.01% | 4849 |
|
|
2021
Q1 | $89K | Buy |
13,470
+9,412
| +232% | +$61.9K | ﹤0.01% | 2680 |
|
|
2020
Q4 | $23K | Sell |
4,058
-7,384
| -65% | -$40.5K | ﹤0.01% | 3789 |
|
|
2020
Q3 | $54K | Buy |
11,442
+4,399
| +62% | +$31.2K | ﹤0.01% | 3511 |
|
|
2020
Q2 | $82K | Buy |
7,043
+6,103
| +649% | +$72.4K | ﹤0.01% | 2640 |
|
|
2020
Q1 | $5K | Sell |
940
-803
| -46% | -$7.19K | ﹤0.01% | 2325 |
|
|
2019
Q4 | $24K | Buy |
1,743
+1,521
| +685% | +$13.4K | ﹤0.01% | 1819 |
|
|
2019
Q3 | $2K | Buy |
222
+198
| +825% | +$1.23K | ﹤0.01% | 3764 |
|
|
2019
Q2 | $0 | Buy |
+24
| New | +$150 | ﹤0.01% | 4465 |
|
|
2019
Q1 | – | Sell |
-2,119
| Closed | -$7K | – | 4422 |
|
|
2018
Q4 | $7K | Buy |
2,119
+1,869
| +748% | +$10.8K | ﹤0.01% | 2731 |
|
|
2018
Q3 | $2K | Buy |
250
+33
| +15% | +$348 | ﹤0.01% | 3505 |
|
|
2018
Q2 | $3K | Sell |
217
-3,231
| -94% | -$33.3K | ﹤0.01% | 3268 |
|
|
2018
Q1 | $35K | Buy |
3,448
+2,138
| +163% | +$24.1K | ﹤0.01% | 1890 |
|
|
2017
Q4 | $17K | Buy |
+1,310
| New | +$16.9K | ﹤0.01% | 2202 |
|
|
2017
Q3 | – | Sell |
-17
| Closed | -$2K | – | 4236 |
|
|
2017
Q2 | $2K | Buy |
+17
| New | +$1.83K | ﹤0.01% | 2393 |
|
|
2017
Q1 | – | Sell |
-50
| Closed | -$4K | – | 4097 |
|
|
2016
Q4 | $4K | Buy |
+50
| New | +$3.79K | ﹤0.01% | 3182 |
|
|
2016
Q3 | – | Sell |
-110
| Closed | -$7.95K | – | 4648 |
|
|
2016
Q2 | $7K | Buy |
110
+88
| +400% | +$5K | ﹤0.01% | 3174 |
|
|
2016
Q1 | $1K | Sell |
22
-111
| -83% | -$5.89K | ﹤0.01% | 3837 |
|
|
2015
Q4 | $10K | Buy |
+133
| New | +$8.92K | ﹤0.01% | 2167 |
|
|
2015
Q2 | – | Sell |
-90
| Closed | -$10K | – | 5178 |
|
|
2015
Q1 | $10K | Buy |
90
+23
| +34% | +$2.7K | ﹤0.01% | 2813 |
|
|
2014
Q4 | $9K | Buy |
67
+34
| +103% | +$3.98K | ﹤0.01% | 2265 |
|
|
2014
Q3 | $4K | Sell |
33
-943
| -97% | -$125K | ﹤0.01% | 3482 |
|
|
2014
Q2 | $164K | Buy |
+976
| New | +$168K | 0.02% | 675 |
|
Other funds holding ARAV
Tower Research Capital (TRC)'s ARAV Position: Q1 2024 in Review
Tower Research Capital (TRC) sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2024, closing a stake of 25,744 shares — an estimated $3.19K sold.
Tower Research Capital (TRC) first reported a position in ARAV in Q2 2014 and held it in 33 quarters. The position peaked at $164K in Q2 2014. 3 funds tracked by Wall St. Rank hold ARAV as of Q1 2024.
- Tower Research Capital (TRC) reported no remaining Aravive, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Tower Research Capital (TRC) sold 25,744 Aravive, Inc. Common Stock shares in Q1 2024, an estimated $3.19K.
- Tower Research Capital (TRC) first reported a position in Aravive, Inc. Common Stock in Q2 2014 and held it in 33 quarters.
- Tower Research Capital (TRC)'s Aravive, Inc. Common Stock position peaked at $164K in Q2 2014.
- 3 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2024.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.